Stability of alpha-[11C]methyl-L-tryptophan brain trapping in healthy male volunteers. 2005

Pedro Rosa-Neto, and Mirko Diksic, and Marco Leyton, and Shadreck Mzengeza, and Chawki Benkelfat
Department of Neurology and Neurosurgery, McGill University, Montreal, QC, H3A 1A1, Canada.

OBJECTIVE The purpose of this study was to assess the reproducibility in healthy volunteers of alpha-[11C]methyl-L-tryptophan (alpha[11C]MT) brain trapping imaging with positron emission tomography (PET), using volumes of interest (VOIs) and voxel-based image analysis. METHODS Six right-handed healthy male volunteers (34.3+/-10.9 years) with a negative family history for psychiatric disorders were scanned twice in the resting condition, 22+/-17 days apart. An unbiased semiautomatic segmentation of the brain was used to define VOIs. The trapping constant K* (ml g(-1) min(-1)) for alpha[11C]MT was calculated for the whole brain and seven brain regions using the graphical method for irreversible tracers. In addition, parametric maps of K* were obtained from dynamic scans using the same method. Comparison of test and retest K* functional images was performed using SPM99. Student's paired t statistic was applied for comparisons of alpha[11C]MT brain trapping in a priori selected VOIs. RESULTS alpha[11C]MT brain trapping in VOIs showed a mean variability 2.6+/-1.8% (0.3-5%) for absolute and 1.5+/-2.1% (1.4-4.1%) for normalized K*. Intraclass correlations between test and retest conditions were 0.61+/-0.34 for absolute K* values and 0.73+/-0.20 for K* values normalized by global mean. SPM99 analysis using a height threshold of p=0.05 (two tailed) and an extent threshold of 100 voxels showed no significant differences between scans. CONCLUSIONS Rest measurements in healthy male volunteers of the trapping constant for alpha[11C]MT, using PET, appeared to be stable during an average interval of 3 weeks.

UI MeSH Term Description Entries
D008297 Male Males
D008657 Metabolic Clearance Rate Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site. Total Body Clearance Rate,Clearance Rate, Metabolic,Clearance Rates, Metabolic,Metabolic Clearance Rates,Rate, Metabolic Clearance,Rates, Metabolic Clearance
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D001931 Brain Mapping Imaging techniques used to colocalize sites of brain functions or physiological activity with brain structures. Brain Electrical Activity Mapping,Functional Cerebral Localization,Topographic Brain Mapping,Brain Mapping, Topographic,Functional Cerebral Localizations,Mapping, Brain,Mapping, Topographic Brain
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D012701 Serotonin A biochemical messenger and regulator, synthesized from the essential amino acid L-TRYPTOPHAN. In humans it is found primarily in the central nervous system, gastrointestinal tract, and blood platelets. Serotonin mediates several important physiological functions including neurotransmission, gastrointestinal motility, hemostasis, and cardiovascular integrity. Multiple receptor families (RECEPTORS, SEROTONIN) explain the broad physiological actions and distribution of this biochemical mediator. 5-HT,5-Hydroxytryptamine,3-(2-Aminoethyl)-1H-indol-5-ol,Enteramine,Hippophaine,Hydroxytryptamine,5 Hydroxytryptamine

Related Publications

Pedro Rosa-Neto, and Mirko Diksic, and Marco Leyton, and Shadreck Mzengeza, and Chawki Benkelfat
December 2005, The international journal of neuropsychopharmacology,
Pedro Rosa-Neto, and Mirko Diksic, and Marco Leyton, and Shadreck Mzengeza, and Chawki Benkelfat
May 2016, Nuclear medicine and biology,
Pedro Rosa-Neto, and Mirko Diksic, and Marco Leyton, and Shadreck Mzengeza, and Chawki Benkelfat
September 2000, Journal of psychiatry & neuroscience : JPN,
Pedro Rosa-Neto, and Mirko Diksic, and Marco Leyton, and Shadreck Mzengeza, and Chawki Benkelfat
March 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Pedro Rosa-Neto, and Mirko Diksic, and Marco Leyton, and Shadreck Mzengeza, and Chawki Benkelfat
March 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism,
Pedro Rosa-Neto, and Mirko Diksic, and Marco Leyton, and Shadreck Mzengeza, and Chawki Benkelfat
April 1995, Nuclear medicine and biology,
Pedro Rosa-Neto, and Mirko Diksic, and Marco Leyton, and Shadreck Mzengeza, and Chawki Benkelfat
April 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism,
Pedro Rosa-Neto, and Mirko Diksic, and Marco Leyton, and Shadreck Mzengeza, and Chawki Benkelfat
February 2007, NeuroImage,
Pedro Rosa-Neto, and Mirko Diksic, and Marco Leyton, and Shadreck Mzengeza, and Chawki Benkelfat
June 2002, Neurochemistry international,
Pedro Rosa-Neto, and Mirko Diksic, and Marco Leyton, and Shadreck Mzengeza, and Chawki Benkelfat
May 2008, Epilepsia,
Copied contents to your clipboard!